Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
The composition of ORAAL is protected by a granted patent in India until November 2033
The products will be manufactured at the company's facility in Bengaluru
The cognitively operated system is a mother patent invention, first launched in India
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Subscribe To Our Newsletter & Stay Updated
